| |
|
|
|
Synthetic Biologics Inc.  
|
|
0.3887 -0.008 (-0.02%) |
11-20 16:00 |
|
Open: |
0 |
Pre close: |
0.3967 |
Target:
|
0.51
|
|
High: |
0 |
Low: |
0 |
Resistance:
|
0.44
0.47
|
|
Volume: |
0 |
Market Cap: |
7M |
Support:
|
0.38
0.32
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.40
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.42 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
0.46 |
Stochastic Oscillator |
%K(14,3):
|
12.50 |
|
MA(250): |
0.56 |
%D(3): |
19.44 |
|
Average Volume(K) |
3-Month: |
7684
|
52-Week |
High:
|
0.85 |
|
10-Days: |
7501 |
Low: |
0.37 |
|
RSI |
RSI(14):
|
38.18 |
Change(%): |
-52.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.783 |
Return on Equity (ttm) |
-146.1 |
Shares Out. (M) |
16.81 |
|
EPS Est. Current Year |
-0.170 |
Return on Assets (ttm) |
-62.3 |
Shares Float (M) |
15.78 |
|
EPS Est. Next Year |
-0.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.10 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
20.67 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
184 |
|
Book Value (p.s.) |
0.010 |
EBITDA (p.s.) |
-0.920 |
P/E |
-0.22 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
38.87 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.56 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-7.96 |
P/CF |
-0.48 |
|
|
|
|
|
|
